Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans

scientific article

Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00125-005-1932-Y
P698PubMed publication ID16143861
P5875ResearchGate publication ID7617309

P50authorSteven E. KahnQ41640212
P2093author name stringQ Xiao
J Tong
R L Hull
S Zraika
R H Knopp
D B Carr
J S Mistry
T M Wallace
K M Utzschneider
B M Retzlaff
P2860cites workAn inflammatory cascade leading to hyperresistinemia in humansQ24796813
The hormone resistin links obesity to diabetesQ29616100
Adipose tissue as an endocrine organQ29620407
Correlation between serum resistin level and adiposity in obese individualsQ33967739
Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjectsQ34311869
High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima IndiansQ40514603
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activatorsQ44263788
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndromeQ44995548
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetesQ45081266
Resistin is an inflammatory marker of atherosclerosis in humans.Q53870894
P433issue11
P921main subjectmetabolic syndromeQ657193
preproinsulinQ7240673
P304page(s)2330-2333
P577publication date2005-09-06
P1433published inDiabetologiaQ5270140
P1476titleResistin is not associated with insulin sensitivity or the metabolic syndrome in humans
P478volume48

Reverse relations

cites work (P2860)
Q37672876Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes
Q29619393Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Q38935290Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.
Q39250237Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis
Q33948483Adipose tissue and vascular inflammation in coronary artery disease
Q37340306Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?
Q37340350Adipose tissue: the new endocrine organ? A review article
Q47220057Age-Associated Decline in Dendritic Cell Function and the Impact of Mediterranean Diet Intervention in Elderly Subjects
Q53305009Association between adiponectin, resistin, insulin resistance, and colorectal tumors.
Q35747118Association of Resistin with Insulin Resistance and Factors of Metabolic Syndrome in North Indians.
Q35245193Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome
Q47978333CNS Targets of Adipokines
Q35829203Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns
Q38343028EGFL6 is increasingly expressed in human obesity and promotes proliferation of adipose tissue-derived stromal vascular cells.
Q28469198Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized study
Q40504566Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sites.
Q36665152High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells
Q35087560Human resistin: found in translation from mouse to man
Q46943466Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism.
Q51472716Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.
Q51498317Increased serum resistin in elite endurance athletes with high insulin sensitivity.
Q36409227Inflammatory mechanisms in the regulation of insulin resistance
Q36582321Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk
Q42145401Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells
Q46165782Insulin resistance without obesity induced by cotton pellet granuloma in mice
Q38985223Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?
Q37377167Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation.
Q36951691Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.
Q38178783Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association
Q37041935Once fat was fat and that was that: our changing perspectives on adipose tissue.
Q37021597Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.
Q38061797Peripheral signalling involved in energy homeostasis control
Q43281626Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population.
Q36830035Potential mechanisms of exercise in gestational diabetes
Q36196397Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers
Q64093563Relationship between Resistin, Endothelin-1, and Flow-Mediated Dilation in Patient with and without Metabolic Syndrome
Q36574933Relationship between deep subcutaneous abdominal adipose tissue and metabolic syndrome: a case control study
Q46535425Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children
Q46745302Resistin correlates with elastase and interleukin-6 in human seminal plasma
Q35025714Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians
Q46712922Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers.
Q34592168Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients.
Q37621780Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis.
Q36271854Resistin: yet another adipokine tells us that men are not mice
Q37497870Reviews: adipocytokines in normal and complicated pregnancies
Q35895869Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus
Q47734576Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance
Q36772021Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy
Q46849188Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes
Q41902978The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais
Q51373468The plasma level and gene expression of resistin in polycystic ovary syndrome.
Q36474596The relation of obesity with serum resistin levels in smoker and nonsmokers.
Q36095970The role of adipokines in connective tissue diseases.
Q34819729Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women
Q51468095Within-subject variation of plasma resistin levels over a 1-year period.

Search more.